Abiomed, Inc. (ABMD) Posts Surprise Q4 Profit; Guides FY12 Revs Above
Tweet
Share
E-mailGet Alerts ABMD Hot Sheet
Price: $381.02 --0%
Financial Fact:
Research and development: 18.05M
Today's EPS Names:
WPRT, ITRG, ALM, More
Financial Fact:
Research and development: 18.05M
Today's EPS Names:
WPRT, ITRG, ALM, More
Join SI Premium – FREE
Abiomed, Inc. (Nasdaq: ABMD) reported Q4 EPS of $0.01, $0.05 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $28.5 million versus the consensus estimate of $27.71 million.
Sees FY12 revenue of $120 - $125 million, versus the consensus of $119.36 million.
Sees FY12 revenue of $120 - $125 million, versus the consensus of $119.36 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
- Mount Logan Capital Inc. (MLCI) Reports Q2 Loss of $0.37
- RideNow Group, Inc. (RDNW) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
